RecruitingNot ApplicableNCT06978777
Effect of Caffeine on Cold-stimulated Brown Adipose Tissue Activity
Sponsor
University Hospital, Basel, Switzerland
Enrollment
12 participants
Start Date
Jan 21, 2026
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of the study is to asses brown adipose tissue activity after a cold mild stimulus, preceded by 200mg caffeine or placebo administration.
Eligibility
Min Age: 18 YearsMax Age: 40 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a drug called Caffeine (200 mg) and a drug called Placebo for people with brown adipose tissue (bat) physiology and cold exposure. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 40 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGCaffeine (200 mg)
single dose of 200mg caffeine orally in study visit A
DRUGPlacebo
single dose of 1 tablet Placebo in study visit B
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06978777
Related Trials
Intermittent Cold Exposure and Brown Adipose Tissue Hyperplasia
NCT070484051 location
Controlled Cold Exposure Combined With PD-1/PD-L1 Immunotherapy in Solid Tumors (NIVALIS)
NCT075384791 location
Omega-3 Fatty Acids as Regulators of Brown Adipose Tissue During Cold Exposure
NCT058221411 location
Molecular, Cellular, and Genetic Characterization of Human Adipose Tissue and Its Role in Metabolism
NCT026928851 location
Energy Dense Fueling for Cold-Weather Operations
NCT074896901 location